Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Boy Killed in Pedestrian Crash at Lafayette Street and Agnew Road


15-Year-Old Hit by Car in Fatal Santa Clara Accident

Pedestrian Fatality

Santa Clara, CA (February 16, 2020) – A 15-year-old boy was killed in a pedestrian crash in Santa Clara. The fatal accident occurred on the evening of February 16 at Lafayette Street and Agnew Road.

A Honda Accord hit the boy at the intersection. According to witnesses, the Honda had the right of way to continue through the intersection. The boy was crossing the street against the “Do not walk” sign. The boy, from Santa Clara, died at the accident scene. The driver remained at the scene. The intersection was closed for several hours.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Santa Clara

#95054


February 5, 2020

Tapelu Tapelu Killed in Crash on Condit Road

Victim Involved in Fatal Head-on Accident in Morgan Hill...


October 30, 2019

2 Injured in Crash on Highway 54 Near Interstate 805

3 Vehicles Involved in National City Accident...


December 11, 2019

Edward Albano Killed in Pedestrian Crash on Temple Avenue

Man Hit by Car in Fatal Pomona Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.